Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,636 Cr
up ₹270 Cr vs Apr 2026
- Stocks held
- 34
- unchanged
- Top 10 weight
- 58.8%
- of the portfolio in its ten largest
- Cash & debt
- 2.1%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 14
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In May 2026 it disclosed 34 stocks worth ₹8,636 Cr, up ₹270 Cr from Apr 2026. Its largest positions were Sun Pharmaceutical Industries Limited (13.3%), Lupin Limited (7.3%), Dr. Reddy's Laboratories Limited (6.7%); the ten largest together made up 58.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 73.4% of its equity. Cash and debt stood at 2.1%. Compared with Apr 2026 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
21%
Holds more stocks than 21% of peers
Cash
31%
Holds more cash than 31% of peers
Holdings in May 2026
Download CSVEvery line the fund disclosed, with the change against Apr 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.35%
- Δ weight
- down 0.50 pts
- Value
- ₹1,153 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 7.31%
- Δ weight
- down 0.64 pts
- Value
- ₹631 Cr
- Δ value
- down ₹33.5 Cr
- Status
- Trimmed
- Weight
- 6.72%
- Δ weight
- down 0.32 pts
- Value
- ₹580 Cr
- Δ value
- down ₹8.6 Cr
- Status
- Trimmed
- Weight
- 6.16%
- Δ weight
- up 0.69 pts
- Value
- ₹532 Cr
- Δ value
- up ₹74 Cr
- Status
- Added
- Weight
- 5.80%
- Δ weight
- down 0.82 pts
- Value
- ₹501 Cr
- Δ value
- down ₹52.7 Cr
- Status
- Trimmed
- Weight
- 5.20%
- Δ weight
- up 0.19 pts
- Value
- ₹449 Cr
- Δ value
- up ₹29.6 Cr
- Status
- Added
- Weight
- 3.94%
- Δ weight
- up 0.90 pts
- Value
- ₹340 Cr
- Δ value
- up ₹85.8 Cr
- Status
- Added
- Weight
- 3.68%
- Δ weight
- down 0.11 pts
- Value
- ₹317 Cr
- Δ value
- up ₹1 Cr
- Status
- Held
- Weight
- 3.43%
- Δ weight
- up 0.17 pts
- Value
- ₹296 Cr
- Δ value
- up ₹23.1 Cr
- Status
- Added
- Weight
- 3.21%
- Δ weight
- up 0.02 pts
- Value
- ₹277 Cr
- Δ value
- up ₹10 Cr
- Status
- Added
- Weight
- 3.21%
- Δ weight
- down 0.15 pts
- Value
- ₹277 Cr
- Δ value
- down ₹3.8 Cr
- Status
- Trimmed
- Weight
- 2.97%
- Δ weight
- down 0.18 pts
- Value
- ₹257 Cr
- Δ value
- down ₹7.4 Cr
- Status
- Trimmed
- Weight
- 2.56%
- Δ weight
- up 0.45 pts
- Value
- ₹221 Cr
- Δ value
- up ₹45 Cr
- Status
- Added
- Weight
- 2.41%
- Δ weight
- down 0.09 pts
- Value
- ₹208 Cr
- Δ value
- down ₹89 L
- Status
- Held
- Weight
- 2.34%
- Δ weight
- down 0.21 pts
- Value
- ₹202 Cr
- Δ value
- down ₹11.5 Cr
- Status
- Trimmed
- Weight
- 2.32%
- Δ weight
- down 0.51 pts
- Value
- ₹200 Cr
- Δ value
- down ₹36.5 Cr
- Status
- Trimmed
- Weight
- 2.31%
- Δ weight
- up 0.06 pts
- Value
- ₹200 Cr
- Δ value
- up ₹10.9 Cr
- Status
- Added
- Weight
- 2.09%
- Δ weight
- up 0.41 pts
- Value
- ₹180 Cr
- Δ value
- up ₹40 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 2.08%
- Δ weight
- up 0.76 pts
- Value
- ₹180 Cr
- Δ value
- up ₹69.5 Cr
- Status
- Added
- Weight
- 2.06%
- Δ weight
- down 0.03 pts
- Value
- ₹178 Cr
- Δ value
- up ₹3.2 Cr
- Status
- Added
- Weight
- 1.90%
- Δ weight
- down 0.10 pts
- Value
- ₹164 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 1.81%
- Δ weight
- up 0.07 pts
- Value
- ₹156 Cr
- Δ value
- up ₹10.5 Cr
- Status
- Added
- Weight
- 1.79%
- Δ weight
- up 0.36 pts
- Value
- ₹155 Cr
- Δ value
- up ₹35 Cr
- Status
- Added
- Weight
- 1.69%
- Δ weight
- down 0.10 pts
- Value
- ₹146 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 1.47%
- Δ weight
- down 0.03 pts
- Value
- ₹127 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 1.29%
- Δ weight
- down 0.03 pts
- Value
- ₹111 Cr
- Δ value
- up ₹72 L
- Status
- Added
- Weight
- 1.19%
- Δ weight
- down 0.03 pts
- Value
- ₹102 Cr
- Δ value
- up ₹61 L
- Status
- Added
- Weight
- 1.14%
- Δ weight
- down 0.08 pts
- Value
- ₹98 Cr
- Δ value
- down ₹3.7 Cr
- Status
- Trimmed
- Weight
- 0.93%
- Δ weight
- down 0.03 pts
- Value
- ₹80.4 Cr
- Δ value
- down ₹2 L
- Status
- Held
- Weight
- 0.92%
- Δ weight
- down 0.07 pts
- Value
- ₹79.5 Cr
- Δ value
- down ₹3.5 Cr
- Status
- Trimmed
- Weight
- 0.83%
- Δ weight
- down 0.11 pts
- Value
- ₹71.3 Cr
- Δ value
- down ₹7.1 Cr
- Status
- Trimmed
- Weight
- 0.73%
- Δ weight
- up 0.10 pts
- Value
- ₹63 Cr
- Δ value
- up ₹10.1 Cr
- Status
- Added
- Weight
- 0.63%
- Δ weight
- up 0.01 pts
- Value
- ₹54 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 0.45%
- Δ weight
- down 0.01 pts
- Value
- ₹38.5 Cr
- Δ value
- up ₹3 L
- Status
- Held
- Weight
- 0.14%
- Δ weight
- down 0.02 pts
- Value
- ₹11.7 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
What changed, Apr 2026 to May 2026
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Mankind Pharma Limitedup ₹85.8 Cr (+0.90% pts)
- Cipla Limitedup ₹74 Cr (+0.69% pts)
- Thyrocare Technologies Limitedup ₹45 Cr (+0.45% pts)
- Gland Pharma Limitedup ₹40 Cr (+0.41% pts)
- Syngene International Limitedup ₹35 Cr (+0.36% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2026, the weight rose most in Healthcare Services (+0.8 pts), and fell most in Pharmaceuticals & Biotechnology (−0.7 pts).
- Healthcare Services21.6% → 22.4%+0.8 pts
- Pharmaceuticals & Biotechnology74.1% → 73.4%−0.7 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2023 | May 2025 | Nov 2025 | Feb 2026 | Apr 2026 | May 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.3% | 75.8% | 75.2% | 74.2% | 74.1% | 73.4% |
| Healthcare Services | 18.5% | 19.4% | 20.8% | 21.7% | 21.6% | 22.4% |
| Retailing | 3.5% | 4.3% | 3.5% | 3.7% | 3.8% | 3.8% |
| Pharmaceuticals | 1.4% | 0.6% | 0.6% | 0.4% | 0.5% | 0.5% |
Allocation in May 2026change vs Apr 2026
- Pharmaceuticals & Biotechnology (23)73.4%▼ 0.7 pts
- Healthcare Services (9)22.4%▲ 0.8 pts
- Retailing (1)3.8%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, May 2026
2.1%
▲ 0.8 pts vs Apr 2026
- Cash alone
- 2.0%
- cash and net receivables
- A year earlier
- 1.4%
- May 2025 · now ▲ 0.7 pts
- Last 12 months
- 0.3% – 2.6%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.